Global Cancer News

Blood test can quickly match advanced breast cancer patients to targeted treatments


A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatments more quickly in the future, Cancer Research UK scientists have found. As part of the plasmaMATCH clinical trial, funded by Stand Up To Cancer, a joint fundraising campaign from Cancer Research UK and Channel 4, the researchers were able to detect mutations in the DNA from the tumours, which had been shed into the bloodstream.


To learn more, see: